Neonatal Intensive Care Drug Manual




Download 1,5 Mb.
bet538/654
Sana03.01.2022
Hajmi1,5 Mb.
#14803
1   ...   534   535   536   537   538   539   540   541   ...   654
References

1. Vemgal P, Ohlsson A. Interventions for non‐oliguric hyperkalaemia in preterm neonates. Cochrane Database of Systematic Reviews. 2012(5).

2. Online M. Resonium A Powder for suspension and Calcium resonium powder for suspension. Accessed on 21 January 2021

3. Hu P-S, Su B-H, Peng C-T, Tsai C-H. Glucose and insulin infusion versus kayexalate for the early treatment of non-oliguric hyperkalemia in very-low-birth-weight infants. Acta Paediatrica Taiwanica. 1999;40(5):314-8.

4. Malone TA. Glucose and insulin versus cation-exchange resin for the treatment of hyperkalemia in very low birth weight infants. The Journal of pediatrics. 1991;118(1):121-3.

5. Singh BS, Sadiq HF, Noguchi A, Keenan WJ. Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates. The Journal of pediatrics. 2002;141(1):16-20.

6. Lillemoe K, Romolo J, Hamilton SR, Pennington L, Burdick JF, Williams G. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery. 1987;101(3):267-72.

7. Dardik A, Moesinger RC, Efron G, Barbul A, Harrison MG. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. Southern medical journal. 2000;93(5):511-3.

8. Milley JR, Jung AL. Hematochezia associated with the use of hypertonic sodium polystyrene sulfonate enemas in premature infants. Journal of perinatology: official journal of the California Perinatal Association. 1995;15(2):139-42.

9. Bennett LN, Myers TF, Lambert GH. Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia. American journal of perinatology. 1996;13(03):167-70.

10. Grammatikopoulos T, Greenough A, Pallidis C, Davenport M. Benefits and risks of calcium resonium therapy in hyperkalaemic preterm infants. Acta Paediatrica. 2003;92(1):118-20.

11. Yaseen H, Khalaf M, Dana A, Yaseen N, Darwich M. Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants. Am J Perinatol. 2008;25(3):193-7.




Original version Date: 9/1/2014

Author: AK, JD

Current Version number: 2

Current Version Date: 7/1/2021

Risk Rating: Low

Due for Review: 7/1/2026

Approval by: DTC

Approval Date: TBA



Download 1,5 Mb.
1   ...   534   535   536   537   538   539   540   541   ...   654




Download 1,5 Mb.

Bosh sahifa
Aloqalar

    Bosh sahifa



Neonatal Intensive Care Drug Manual

Download 1,5 Mb.